Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 Ballot 3 World

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

EvidenceVariable: Percentage of Participants With Potentially Related Adverse Events (NCT03640312)

Computable Name:

version: 30; Last updated: 2026-09-02 17:12:13+0000

Profile: VariableDefinition

ArtifactPublicationStatus: Active

url: https://fevir.net/resources/EvidenceVariable/367897

identifier: FEvIR Object Identifier/367897, FEvIR Linking Identifier/NCT03640312-otherOutcome-1

name: Percentage_of_Participants_With_Potentially_Related_Adverse_Events_NCT03640312

title: Percentage of Participants With Potentially Related Adverse Events (NCT03640312)

citeAs:

Percentage of Participants With Potentially Related Adverse Events (NCT03640312) [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 367897. Revised 2026-09-02. Available at: https://fevir.net/resources/EvidenceVariable/367897. Computable resource at: https://fevir.net/resources/EvidenceVariable/367897#json.

status: Active

author: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter:

publisher: Computable Publishing LLC

contact: support@computablepublishing.com

description:

Percentage of participants with occurrence of any potentially related adverse event (pre-specified as in study procedures). Defined as: At least possibly related to study drug.

copyright:

Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).

Definitions

-Concept
*Percentage of Participants With Potentially Related Adverse Events Percentage of participants with occurrence of any potentially related adverse event (pre-specified as in study procedures). Defined as: At least possibly related to study drug.

handling: Evidence variable handling not specified

Timings

-Text
*12 weeks